Lamba V, Jia B, Liang F
Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL 32610, United States.
Department of Biostatistics, University of Florida, Gainesville, FL 32611, United States.
Biochem Biophys Res Commun. 2016 Oct 14;479(2):117-124. doi: 10.1016/j.bbrc.2016.06.011. Epub 2016 Jun 3.
STAT5A and STAT5B are important transcription factors that play a key role in regulation of several important physiological processes including proliferation, survival, mediation of responses to cytokines and in regulating gender differences in drug response genes such as the hepatic cytochrome P450s (CYPs) that are responsible for a large majority of drug metabolism reactions in the human body. STAT5A and STAT5b have a high degree of sequence homology and have been reported to have largely similar functions. Recent studies have, however, indicated that they can also often have distinct and unique roles in regulating gene expression.
In this study, we evaluated the association of STAT5A and STAT5B mRNA expression levels with those of several key hepatic cytochrome P450s (CYPs) and hepatic transcription factors (TFs) and evaluated the potential roles of STAT5A and 5b in mediating gender differences in these CYPs and TFs.
Expression profiling for major hepatic CYP isoforms and transcription factors was performed using RNA sequencing (RNA-seq) in 102 human liver samples (57 female, 45 male). Real time PCR gene expression data for selected CYPs and TFs was available on a subset of 50 human liver samples (25 female, 25 male) and was used to validate the RNA-seq findings.
While STAT5A demonstrated significant negative correlation with expression levels of multiple hepatic transcription factors (including NR1I2 and HNF4A) and DMEs such as CYP3A4 and CYP2C19, STAT5B expression was observed to demonstrate positive associations with several CYPs and TFs analyzed. As STAT5A and STAT5B have been shown to be important in regulation of gender differences in CYPs, we also analyzed STAT5A and 5b associations with CYPs and TFs separately in males and females and observed gender dependent differential associations of STATs with several CYPs and TFs. Results from the real time PCR validation largely supported our RNA-seq findings.
Using both RNA sequencing and real time PCR, we examined the association of STAT5A and STAT5B mRNA expression with CYP and TF gene expression. While STAT5A demonstrated significant negative correlations with expression levels of multiple hepatic TFs (including NR1I2 and HNF4α) and CYPs (eg. CYP3A4, CYP2C19), STAT5B expression was observed to demonstrate positive association with most of the CYPs/TFs analyzed suggesting that STAT5A and STAT5b have potentially different and distinct roles in regulating expression of hepatic drug response genes. Further studies are needed to elucidate the potential roles of STAT5A and 5b in regulation of CYPs/TFs and the potential implications of these findings.
信号转导和转录激活因子5A(STAT5A)和信号转导和转录激活因子5B(STAT5B)是重要的转录因子,在调节多个重要生理过程中发挥关键作用,这些生理过程包括增殖、存活、细胞因子反应介导以及调节药物反应基因中的性别差异,如肝细胞色素P450酶(CYPs),它们负责体内大部分药物代谢反应。STAT5A和STAT5B具有高度序列同源性,据报道功能基本相似。然而,最近的研究表明,它们在调节基因表达方面也常常具有不同且独特的作用。
在本研究中,我们评估了STAT5A和STAT5B mRNA表达水平与几种关键肝细胞色素P450酶(CYPs)和肝转录因子(TFs)表达水平的相关性,并评估了STAT5A和5B在介导这些CYPs和TFs性别差异中的潜在作用。
使用RNA测序(RNA-seq)对102份人类肝脏样本(57份女性样本,45份男性样本)进行主要肝CYP亚型和转录因子的表达谱分析。50份人类肝脏样本(25份女性样本,25份男性样本)的子集可获得所选CYPs和TFs的实时PCR基因表达数据,并用于验证RNA-seq结果。
虽然STAT5A与多种肝转录因子(包括NR1I2和HNF4A)以及药物代谢酶(如CYP3A4和CYP2C19)的表达水平呈显著负相关,但观察到STAT5B表达与所分析的几种CYPs和TFs呈正相关。由于已证明STAT5A和STAT5B在调节CYPs性别差异中很重要,我们还分别分析了男性和女性中STAT5A和5B与CYPs和TFs的相关性,并观察到STATs与几种CYPs和TFs存在性别依赖性差异相关性。实时PCR验证结果在很大程度上支持了我们的RNA-seq结果。
我们使用RNA测序和实时PCR检测了STAT5A和STAT5B mRNA表达与CYP和TF基因表达的相关性。虽然STAT5A与多种肝TFs(包括NR1I2和HNF4α)和CYPs(如CYP3A4、CYP2C19)的表达水平呈显著负相关,但观察到STAT5B表达与大多数所分析的CYPs/TFs呈正相关,这表明STAT5A和STAT5B在调节肝药物反应基因表达方面可能具有不同且独特的作用。需要进一步研究以阐明STAT5A和5B在调节CYPs/TFs中的潜在作用以及这些发现的潜在意义。